The Obstacle Course of Reperfusion for ST-Segment–Elevation Myocardial Infarction in the COVID-19 Pandemic
2020; Lippincott Williams & Wilkins; Volume: 141; Issue: 24 Linguagem: Inglês
10.1161/circulationaha.120.047523
ISSN1524-4539
AutoresMarco Roffi, Giulio Guagliumi, Borja Ibáñez,
Tópico(s)Cardiovascular Effects of Exercise
ResumoHomeCirculationVol. 141, No. 24The Obstacle Course of Reperfusion for ST-Segment–Elevation Myocardial Infarction in the COVID-19 Pandemic Free AccessArticle CommentaryPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessArticle CommentaryPDF/EPUBThe Obstacle Course of Reperfusion for ST-Segment–Elevation Myocardial Infarction in the COVID-19 Pandemic Marco Roffi, Giulio Guagliumi and Borja Ibanez Marco RoffiMarco Roffi Marco Roffi, MD, Director, Interventional Cardiology Unit, Geneva University Hospitals, Rue Gabrielle Perret-Gentil 4, 1211 Geneva 14, Switzerland. Email E-mail Address: [email protected] Cardiology Division, University Hospitals, Geneva, Switzerland (M.R.). , Giulio GuagliumiGiulio Guagliumi Interventional Cardiology, Cardiovascular Department, Papa Giovanni Hospital, Bergamo, Italy (G.G.). and Borja IbanezBorja Ibanez Centro Nacional de Investigaciones Caridovasculares Carlos III (CNIC), Madrid, Spain (B.I.). Department of Cardiology, IIS-Fundación Jiménez Díaz Hospital, Madrid, Spain (B.I.). CIBERCV, Madrid, Spain (B.I.). Originally published21 Apr 2020https://doi.org/10.1161/CIRCULATIONAHA.120.047523Circulation. 2020;141:1951–1953Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: April 21, 2020: Ahead of Print Coronavirus disease 2019 (COVID-19) infection, caused by the severe acute respiratory syndrome coronavirus 2, poses a double threat to public health: The immediate threat is the morbidity and mortality related to the infection, and the more subtle threat is the shift of attention and resources away from the care of regular diseases.Patient- and Healthcare Network–Related FactorsMultiple investigators across Europe have reported a reduction in patients admitted for ST-segment–elevation myocardial infarction (STEMI) since the COVID pandemic began.1 This may be the result of a decreased awareness/shift of attention of patients, the desire not to overload the emergency medical systems (EMS), and the fear of infection and not receiving proper treatment, as well. For similar reasons, clinicians and nurses visiting patients at home or nursing homes may have a higher threshold to refer patients with chest pain to the emergency departments (Figure). An EMS alert may be challenging because of jammed phone lines and a limited number of ambulances. Trained ambulance personnel may not be available to make STEMI diagnosis on site. In addition, shared experiences estimate an up to 60-minute increase in intrinsic delay from diagnosis to reperfusion with primary percutaneous coronary intervention (PCI) in regions deeply affected by the COVID-19 pandemic, because of suboptimal EMS availability and the implementation of personal protective equipment at any level of care (prehospital, emergency department, and cardiac catheterization laboratory). Moreover, uncertainty regarding diagnosis, given reports of myopericarditis presenting as a STEMI mimic, may add to delays. Spoke centers may have been converted to COVID hospitals, may be more restrictive in transferring patients who have STEMI for primary PCI, and may adopt fibrinolytic treatment without subsequent systematic referral for angiography. It is important to note that the safety and efficacy of fibrinolysis in patients with COVID-19 presenting with ST elevation who may have associated myopericarditis or coagulopathy, ranging from isolated d-dimer level elevation observed in up to 40% of patients to disseminated intravascular coagulation, remain unknown.2Download figureDownload PowerPointFigure. Obstacles affecting timely reperfusion in ST-segment–elevation myocardial infarction (STEMI) at the patient, emergency services (EMS), and institutional levels during the COVID-19 pandemic. Although patient and primary care workers may be reluctant to call EMS, it is estimated that the overload of the healthcare systems, the increase in transportation time, and the need for personal protection equipment (PPE) may increase the time to reperfusion up to 60 minutes. Late presentations are more common and decrease the efficacy of both primary percutaneous coronary intervention (PCI) and fibrinolytic therapy. An increase in complications of myocardial infarction, such as pump failure, ventricular arrhythmias, and mechanical complications, is expected. COVID-19 indicates coronavirus disease 2019; and ICU, intensive care unit.Impact on Primary PCIIn patients with STEMI and multivessel coronary artery disease, guidelines recommend complete revascularization, which in many institutions is performed as a staged procedure. In the COVID-19 pandemic, 2 considerations based on the disease complexity may change this strategy. If the culprit lesion has been treated successfully with no complications, the additional coronary lesions are easily accessible, and the patient is hemodynamically stable, immediate complete revascularization may be an attractive guideline-conforming option to avoid a staged procedure, which would prolong the hospital stay or require a second admission and additional personnel exposure if the patient is COVID-19 positive.3 If revascularization of the culprit lesion has been challenging or associated with a complication (eg, no reflow), the patient is unstable, or a nonculprit disease would require complex PCI, the operator may opt for medical management of the nonculprit disease to avoid the risk of hemodynamic deterioration and the need for (prolonged) intensive care unit surveillance.Bergamo's ExperienceAt the end of February 2020, the city of Bergamo, Italy, became the place where COVID-19 hit Europe first and in the hardest way. The EMS, one of the most efficient local and regional networks for time-dependent disease transportation in Italy, was flooded by calls of patients in severe respiratory distress. During a 40-day period starting February 23, 2020, the emergency department of the Papa Giovanni Hospital (where one of the authors [Dr Guagliumi] practices) admitted 1407 patients with interstitial pneumonia, >400 and 150 of them requiring noninvasive ventilation and endotracheal intubation, respectively. A survey from administrative data, provided by 138 municipalities representing 70% of the total population in the province of Bergamo, showed that >5400 people died in March 2020, 6 times more than in the corresponding month of the previous year.4 Among them, 2060 were COVID-19 in-hospital deaths, whereas the remaining occurred at home or nursing homes without diagnosis. Therefore, they were not integrated in the COVID-19 statistics.The regional STEMI network was quickly changed into a model of macrohubs to concentrate personnel and urgent activities, such as primary PCI for STEMI or interventional stroke management, while expanding health resources for patients with COVID-19 in all remaining hospitals. Protocols were implemented to allow and regulate separate patient admission of patients with STEMI, from triage through the catheterization laboratory, to reduce cross-infections and to train the personnel to the new personal protective equipment standards. Despite an increase in delays, primary PCI was offered to most patients with STEMI. The decision was made not to perform primary PCI, and instead administer fibrinolytic treatment, in patients with COVID-19 presenting with severe respiratory distress syndrome but not qualifying for endotracheal intubation based on age or comorbidities. All patients in severe respiratory distress undergoing primary PCI were intubated before arrival at the catheterization laboratory to minimize contamination. During the month of March 2020, a marked reduction in primary PCI for STEMI (–37%) and an increase in late presentations (+25%) were observed in the province, in comparison with the monthly average of the previous year. Extensive infarctions, heart failure, high coronary thrombus burden, and no reflow were more frequent.Madrid's ExperienceSpain was among the countries that have been hit hard by the COVID-19 pandemic, with >166 000 infected people and >17 000 deaths (~350 per million inhabitants) as of April 12, 2020. Madrid (where one of the authors [Dr Ibanez] practices) was the region of Spain with the highest prevalence of the disease, with >47 000 confirmed cases and ≈6300 deaths (≈870 deaths per million inhabitants) on the same date. According to the Spanish Ministry of Health, the first patient with COVID-19 was admitted to intensive care in Madrid on March 8, whereas the peak of patients with COVID-19 in intensive care was achieved on April 5 with 1510 patients). The pandemic has disrupted the Codigo Infarto Madrid, a successful STEMI network treating ≈2500 patients with STEMI per year, >98% of them by primary PCI, in 11 catheterization laboratories 24/7. The main challenge in the Madrid area, and in other affected areas of Spain, as well, has been the saturation of the EMS. A survey conducted in Madrid showed that the number of primary PCIs has been reduced by half since the inception of the COVID-19 pandemic in comparison with the previous weeks. This has been accompanied by a slight increase in the use of fibrinolysis, mainly in patients presenting at non-PCI centers.5 After a massive reduction in patients seeking EMS for chest pain, the cardiology community in the region is performed a public awareness campaign in newspapers and social media. Primary PCI program remained the preferred reperfusion strategy in the region, provided it could be done in a timely manner. All patients were handled as potential COVID-19 positive.ConclusionThe COVID-19 pandemic represents an unprecedented challenge for healthcare systems and negatively affects time-dependent care of acute cardiovascular conditions such as STEMI. Two European cities hit hard, Bergamo, Italy, and Madrid, Spain, are examples.DisclosuresNone.FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.https://www.ahajournals.org/journal/circMarco Roffi, MD, Director, Interventional Cardiology Unit, Geneva University Hospitals, Rue Gabrielle Perret-Gentil 4, 1211 Geneva 14, Switzerland. Email marco.roffi@hcuge.chReferences1. Wood S. The mystery of the missing STEMIs during the COVID-19 pandemic. tctMD.April 2, 2020. https://www.tctmd.com/news/mystery-missing-stemis-during-covid-19-pandemic. Accessed April 10, 2020.Google Scholar2. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection [published online March 3, 2020].Clin Chem Lab Med. doi: 10.1515/cclm-2020-0198 https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0198/article-10.1515-cclm-2020-0198.xml. Accessed April 9, 2020.Google Scholar3. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).Eur Heart J. 2018; 39:119–177. doi: 10.1093/eurheartj/ehx393CrossrefMedlineGoogle Scholar4. Invernizzi I. Coronavirus, the real death toll: 4,500 victims in one month in the province of Bergamo.Newspaper Eco di Bergamo. April 1, 2020. https://www.ecodibergamo.it/stories/bergamo-citta/coronavirus-the-real-death-tool-4500-victims-in-one-month-in-the-province-of_1347414_11. Accessed April 8, 2020.Google Scholar5. Rodríguez-Leor O, Cid-Álvarez B, Ojeda S, Martín-Moreiras J, Rumoroso JR, López-Palop R, Serrador A, Cequier A, Romaguera R, Cruz I, et al. Impact of the COVID-19 pandemic on interventional cardiology activity in Spain.REC Interv Cardiol. 2020; 2:82–89. doi: 10.24875/RECIC.M20000120Google Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Spadaccio C, Rose D, Candura D, Lopez Marco A, Cerillo A, Stefano P, Nasso G, Ramoni E, Fattouch K, Minacapelli A, Oo A, Speziale G, Shelton K, Berra L, Bose A and Moscarelli M (2024) Effect of Hospital-associated SARS-CoV-2 Infections in Cardiac Surgery: A Multicenter Study, The Annals of Thoracic Surgery, 10.1016/j.athoracsur.2022.05.034, 117:1, (213-219), Online publication date: 1-Jan-2024. Nogueira R, Etter K, Nguyen T, Ikeme S, Wong C, Frankel M, Haussen D, Del Rio C, McDaniel M, Sachdeva R, Devireddy C, Al-Bayati A, Mohammaden M, Doheim M, Pinheiro A, Liberato B, Jillella D, Bhatt N and Khanna R (2023) Changes in the care of acute cerebrovascular and cardiovascular conditions during the first year of the covid-19 pandemic in 746 hospitals in the USA: retrospective analysis, BMJ Medicine, 10.1136/bmjmed-2022-000207, 2:1, (e000207), Online publication date: 1-May-2023. Ghasemzadeh N, Kim N, Amlani S, Madan M, Shavadia J, Chong A, Bagherli A, Bagai A, Saw J, Singh J and Dehghani P (2023) A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19, Heart Failure Clinics, 10.1016/j.hfc.2022.08.007, 19:2, (197-204), Online publication date: 1-Apr-2023. Alharbi A, Franz A, Alfatlawi H, Wazzan M, Alsughayer A, Eltahawy E and Assaly R (2023) Impact of COVID-19 Pandemic on the Outcomes of Acute Coronary Syndrome, Current Problems in Cardiology, 10.1016/j.cpcardiol.2022.101575, 48:4, (101575), Online publication date: 1-Apr-2023. Huggins A, Husaini M, Wang F, Waken R, Epstein A, Orav E and Joynt Maddox K (2023) Care Disruption During COVID-19: a National Survey of Hospital Leaders, Journal of General Internal Medicine, 10.1007/s11606-022-08002-5, 38:5, (1232-1238), Online publication date: 1-Apr-2023. De Luca G, Algowhary M, Uguz B, Oliveira D, Ganyukov V, Busljetik O, Cercek M, Jensen L, Loh P, Calmac L, Ferrer G, Quadros A, Milewski M, Scotto D'Uccio F, von Birgelen C, Versaci F, Ten Berg J, Casella G, Wong Sung Lung A, Kala P, Díez Gil J, Carrillo X, Dirksen M, Becerra Munoz V, Lee M, Juzar D, de Moura Joaquim R, Paladino R, Milicic D, Davlouros P, Bakraceski N, Zilio F, Donazzan L, Kraaijeveld A, Galasso G, Arpad L, Marinucci L, Guiducci V, Menichelli M, Scoccia A, Yamac A, Ugur Mert K, Flores Rios X, Kovarnik T, Kidawa M, Moreu J, Flavien V, Fabris E, Martínez-Luengas I, Boccalatte M, Bosa Ojeda F, Arellano-Serrano C, Caiazzo G, Cirrincione G, Kao H, Sanchis Forés J, Vignali L, Pereira H, Manzo-Silberman S, Ordoñez S, Arat Özkan A, Scheller B, Lehitola H, Teles R, Mantis C, Antti Y, Brum Silveira J, Zoni C, Bessonov I, Uccello G, Kochiadakis G, Alexopulos D, Uribe C, Kanakakis J, Faurie B, Gabrielli G, Gutierrez Barrios A, Bachini J, Rocha A, Tam F, Rodriguez A, Lukito A, Saint-Joy V, Pessah G, Tuccillo A, Ielasi A, Cortese G, Parodi G, Burgadha M, Kedhi E, Lamelas P, Suryapranata H, Nardin M and Verdoia M (2023) Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry, Journal of Clinical Medicine, 10.3390/jcm12062116, 12:6, (2116) Pegani C, Buttignon G, Tullio A, Naccarato M, Manganotti P, Rakar S, Fabris E, Nadalin F, Mione V, Gigli G, Lorenzut S, Spedicato L, Passadore P, Pavan D, Lutman C, Andrian M, Borelli M, Novello S, Belfiore R, Daneluzzi C, Sinagra G and Peratoner A (2022) The impact of COVID-19 on myocardial infarctions, strokes and out-of-hospital cardiopulmonary arrests: an observational retrospective study on time-sensitive disorders in the Friuli Venezia Giulia region (Italy), International Journal of Emergency Medicine, 10.1186/s12245-022-00473-x, 15:1, Online publication date: 1-Dec-2022. Santos H, Santos M, B. Paula S, Almeida I, Almeida S, Almeida L and Portuguese Registry of Acute Coronary Syndromes O (2022) The National Response to Patients with Acute Coronary Syndrome during the First Wave of the COVID-19 Pandemic in Portugal, Acta Médica Portuguesa, 10.20344/amp.18610, 35:12, (891-898) BORGHESI M, ZILIO F, BRAITO G, DALLAGO M, MURAGLIA S, TODARO D and BONMASSARI R How to keep the cath-lab of a COVID-free hub center during the pandemic in a hub and spoke cardiology network: a single center's experience, Minerva Cardiology and Angiology, 10.23736/S2724-5683.20.05477-8, 70:4 Ghasemzadeh N, Kim N, Amlani S, Madan M, Shavadia J, Chong A, Bagherli A, Bagai A, Saw J, Singh J and Dehghani P (2022) A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19, Cardiology Clinics, 10.1016/j.ccl.2022.03.007, 40:3, (321-328), Online publication date: 1-Aug-2022. Morishita T, Takada D, Shin J, Higuchi T, Kunisawa S and Imanaka Y (2022) Trends, Treatment Approaches, and In-Hospital Mortality for Acute Coronary Syndrome in Japan During the Coronavirus Disease 2019 Pandemic, Journal of Atherosclerosis and Thrombosis, 10.5551/jat.62746, 29:5, (597-607), Online publication date: 1-May-2022. Fox D, Waken R, Johnson D, Hammond G, Yu J, Fanous E, Maddox T and Joynt Maddox K (2022) Impact of the COVID‐19 Pandemic on Patients Without COVID‐19 With Acute Myocardial Infarction and Heart Failure, Journal of the American Heart Association, 11:6, Online publication date: 15-Mar-2022. De Luca G, Algowhary M, Uguz B, Oliveira D, Ganyukov V, Zimbakov Z, Cercek M, Jensen L, Loh P, Calmac L, Roura-Ferrer G, Quadros A, Milewski M, Scotto di Uccio F, von Birgelen C, Versaci F, Ten Berg J, Casella G, Wong A, Kala P, Diez Gil J, Carrillo X, Dirksen M, Becerra-Muñoz V, Kang-yin Lee M, Juzar D, de Moura Joaquim R, Paladino R, Milicic D, Davlouros P, Bakraceski N, Zilio F, Donazzan L, Kraaijeveld A, Galasso G, Lux A, Marinucci L, Guiducci V, Menichelli M, Scoccia A, Yamac A, Ugur Mert K, Flores Rios X, Kovarnik T, Kidawa M, Moreu J, Flavien V, Fabris E, Lozano Martìnez-Luengas I, Boccalatte M, Bosa Ojeda F, Arellano-Serrano C, Caiazzo G, Cirrincione G, Kao H, Sanchis Fores J, Vignali L, Pereira H, Manzo-Silberman S, Ordonez S, Özkan A, Scheller B, Lehtola H, Teles R, Mantis C, Ylitalo A, Brum Silveira J, Zoni R, Bessonov I, Savonitto S, Kochiadakis G, Alexopoulos D, Uribe C, Kanakakis J, Faurie B, Gabrielli G, Gutiérrez A, Bachini J, Rocha A, Tam F, Rodriguez A, Lukito A, Saint-Joy V, Pessah G, Tuccillo B, Cortese G, Parodi G, Bouraghda M, Kedhi E, Lamelas P, Suryapranata H, Nardin M and Verdoia M (2021) COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction, Heart, 10.1136/heartjnl-2021-319750, 108:6, (458-466), Online publication date: 1-Mar-2022. Morishita T, Takada D, Shin J, Higuchi T, Kunisawa S, Fushimi K and Imanaka Y (2021) Effects of the COVID‐19 pandemic on heart failure hospitalizations in Japan: interrupted time series analysis, ESC Heart Failure, 10.1002/ehf2.13744, 9:1, (31-38), Online publication date: 1-Feb-2022. Abuzeyad F, Chomayil Y, Amin M, Farooq M, Alshaban M, Kamkoun W, Nair S, Alqasem L, Makwana D and Das P (2022) Effects of COVID-19 on STEMI patients: Single-center experience, Heart Views, 10.4103/heartviews.heartviews_40_22, 23:3, (138), . Mitsis A, Eftychiou C, Lakoumentas J, Kyriakou M, Eteokleous N, Zittis I and Avraamides P (2022) Influence of the Second Wave of the COVID-19 Pandemic on the Management of Patients with ST-T Segment Elevation Myocardial Infarction, Chonnam Medical Journal, 10.4068/cmj.2022.58.3.119, 58:3, (119), . Farrington W, Robinson N, Rahouma M, Lau C, Hameed I, Iannacone E, Ivascu N, Mick S, Gaudino M and Girardi L (2022) Cardiac Surgery Outcomes in an Epicenter of the COVID-19 Pandemic, Seminars in Thoracic and Cardiovascular Surgery, 10.1053/j.semtcvs.2021.01.005, 34:1, (182-188), Online publication date: 1-Sep-2023. Medranda G, Brahmbhatt K, Alawneh B, Marzo K, Schwartz R and Green S (2022) Initial Single-Center ST-Segment Elevation Myocardial Infarction Experience in New York Before and During the COVID-19 Pandemic, Cardiovascular Revascularization Medicine, 10.1016/j.carrev.2021.01.026, 34, (80-85), Online publication date: 1-Jan-2022. Mallick U (2022) Acute Coronary Syndromes in CoViD19 Cardiovascular Complications of COVID-19, 10.1007/978-3-030-90065-6_15, (291-304), . Javaid A, Saleh Y, Ahmed A, Saad J, Malahfji M and Al-Mallah M (2021)(2021)(2021) Noninvasive Imaging for Patients with COVID-19 and Acute Chest Pain, Methodist DeBakey Cardiovascular Journal, 10.14797/mdcvj.1040, 17:5, (5-15), Online publication date: 15-Dec-2021., Online publication date: 15-Dec-2021., . Zhang Y, Wang M, Zhang X, Liu T, Libby P and Shi G (2021) COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases, Cardiology Discovery, 10.1097/CD9.0000000000000038, 1:4, (233-258), Online publication date: 1-Dec-2021. Seitlinger J, Wollbrett C, Mazzella A, Schmid S, Guerrera F, Banga Nkomo D, Hassan M, Brindel A, Ruuth-Praz J, Schmitt P, Clément-Duchêne C, Douiri N, Reeb J, Prisciandaro E, Siat J, Spaggiari L, Ruffini E, Filosso P, Ferri L, Santelmo N, Spicer J and Renaud S (2021) Safety and Feasibility of Thoracic Malignancy Surgery During the COVID-19 Pandemic, The Annals of Thoracic Surgery, 10.1016/j.athoracsur.2020.12.001, 112:6, (1870-1876), Online publication date: 1-Dec-2021. Higashikuni Y, Liu W, Obana T and Sata M (2021) Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications, International Journal of Molecular Sciences, 10.3390/ijms222112081, 22:21, (12081) Pacini D, Costantino A, Fiorentino M, Loforte A, Leone A and Botta L (2021) The Triple-Layer Patch Technique for Postinfarction Ventricular Septal Rupture, The Annals of Thoracic Surgery, 10.1016/j.athoracsur.2021.02.086, 112:5, (e377-e380), Online publication date: 1-Nov-2021. McLaren J, Taher A and Chartier L (2021) Flattening the other curve: Reducing emergency department STEMI delays during the COVID-19 pandemic, The American Journal of Emergency Medicine, 10.1016/j.ajem.2021.06.057, 49, (367-372), Online publication date: 1-Nov-2021. Tanaka K, Matsumoto S, Nakazawa Y, Yamada T, Sonoda K, Nagano S, Hatano T, Yamasaki R, Nakahara I and Isobe N (2021) Delays in Presentation Time Under the COVID-19 Epidemic in Patients With Transient Ischemic Attack and Mild Stroke: A Retrospective Study of Three Hospitals in a Japanese Prefecture, Frontiers in Neurology, 10.3389/fneur.2021.748316, 12 Tam D, Qiu F, Manoragavan R, Fremes S, Hassan A, Ko D, Lauck S, Naimark D, Ouzounian M, Sander B, Sun L and Wijeysundera H (2021) The Impact of the COVID-19 Pandemic on Cardiac Procedure Wait List Mortality in Ontario, Canada, Canadian Journal of Cardiology, 10.1016/j.cjca.2021.05.008, 37:10, (1547-1554), Online publication date: 1-Oct-2021. Hodas R, Benedek I, Rat N, Kovacs I, Chitu M and Benedek T (2021) Impact of COVID-19 Pandemic on STEMI Networks in Central Romania, Life, 10.3390/life11101004, 11:10, (1004) Pellegrini D, Fiocca L, Pescetelli I, Canova P, Vassileva A, Faggi L, Senni M and Guagliumi G (2021) Effect of Respiratory Impairment on the Outcomes of Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Coronavirus Disease-2019 (COVID-19), Circulation Journal, 10.1253/circj.CJ-20-1166, 85:10, (1701-1707), Online publication date: 24-Sep-2021. Al Amiry A and Maguire B (2021) Emergency Medical Services (EMS) Calls During COVID-19: Early Lessons Learned for Systems Planning (A Narrative Review), Open Access Emergency Medicine, 10.2147/OAEM.S324568, Volume 13, (407-414) Chew N, Ow Z, Teo V, Heng R, Ng C, Lee C, Low A, Chan M, Yeo T, Tan H and Loh P (2021) The Global Effect of the COVID-19 Pandemic on STEMI Care: A Systematic Review and Meta-analysis, Canadian Journal of Cardiology, 10.1016/j.cjca.2021.04.003, 37:9, (1450-1459), Online publication date: 1-Sep-2021. Mao Q, Zhao J, Li Y, Xie L, Xiao H, Wang K, Qiu Y, Chen J, Xu Q, Xu Z, Yu Y, Zhang Y, Li Q, Pang X, Li Z, Ran B, Zhang Z, Li Z, Zeng C, Tong S, Jin J, Huang L and Zhao X (2021) Impact of COVID-19 Pandemic on Mechanical Reperfusion in ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Multicenter Retrospective Study From a Non-epicenter Region, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2021.698923, 8 Mously H, Shah N, Zuzek Z, Alshaghdali I, Karim A, Jaswaney R, Filby S, Simon D, Shishehbor M and Forouzandeh F (2021) Door-to-balloon Time for ST-elevation MI in the Coronavirus Disease 2019 Era, US Cardiology Review, 10.15420/usc.2021.05, 15 Dušek J, Bis J and Šťásek J (2021) Covid-19 and myocardial infarction, Intervenční a akutní kardiologie, 10.36290/kar.2021.025, 20:2, (82-85), Online publication date: 9-Jul-2021. Chhetry M, Bhatt R, Tehrani N, Avgerinos D, Mack C, Lang S and Dai X (2021) Delayed Treatment of Acute Myocardial Infarction With Ventricular Septal Rupture Due to Patient Fear During the COVID-19 Pandemic, Texas Heart Institute Journal, 10.14503/THIJ-20-7356, 48:3, Online publication date: 1-Jul-2021. Kamarullah W, Sabrina A, Rocky M and Gozali D (2021) Investigating the implications of COVID-19 outbreak on systems of care and outcomes of STEMI patients: A systematic review and meta-analysis, Indian Heart Journal, 10.1016/j.ihj.2021.06.009, 73:4, (404-412), Online publication date: 1-Jul-2021. Zhang F, Song X and Dang Y (2021) Experience of ST Segment Elevation Myocardial Infarction Management During COVID-19 Pandemic From the Mainland of China, Cardiovascular Revascularization Medicine, 10.1016/j.carrev.2020.07.027, 28, (92-94), Online publication date: 1-Jul-2021. Bruoha S, Yosefy C, Gallego-Colon E, Rieck J, Orlov Y, Osherov A, Jihad A, Sherer Y, Viki N and Jafari J (2021) Impact in total ischemic time and ST-segment elevation myocardial infarction admissions during COVID-19, The American Journal of Emergency Medicine, 10.1016/j.ajem.2021.02.020, 45, (7-10), Online publication date: 1-Jul-2021. Lau D and McAlister F (2021) Implications of the COVID-19 Pandemic for Cardiovascular Disease and Risk-Factor Management, Canadian Journal of Cardiology, 10.1016/j.cjca.2020.11.001, 37:5, (722-732), Online publication date: 1-May-2021. Bonnet G, Panagides V, Becker M, Rivière N, Yvorel C, Deney A, Lattuca B, Duband B, Moussa K, Juenin L, Pamart T, Semaan C, Uhry S, Noirclerc N, Vincent F, Vignac M, Palermo V, Martin A, Zeitouni M, Van Belle E, Tirouvanziam A, Manchuelle A, Chamandi C, Kerneis M, Boukantar M, Belle L, De Poli F, Angoulvant D, Meneveau N, Robin M, Pansieri M, Bonello L, Motreff P, Bouisset F, Isaaz K, Cetran L, Khalife K, Lesizza P, Adjedj J, Benamer H and Cayla G (2021) ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France, Archives of Cardiovascular Diseases, 10.1016/j.acvd.2021.01.005, 114:5, (340-351), Online publication date: 1-May-2021. Kumar B, Kodliwadmath A, Upadhyay A, Singh A and N N (2021) Apparently normal epicardial coronaries in a patient with inferior wall myocardial infraction on the background of mild coronavirus disease-2019: take a second look!, Monaldi Archives for Chest Disease, 10.4081/monaldi.2021.1668 Gu S, Tyagi T, Jain K, Gu V, Lee S, Hwa J, Kwan J, Krause D, Lee A, Halene S, Martin K, Chun H and Hwa J (2020) Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation, Nature Reviews Cardiology, 10.1038/s41569-020-00469-1, 18:3, (194-209), Online publication date: 1-Mar-2021. Ishigami J, Kou M, Ding N and Matsushita K (2021) Cardiovascular Disease and Coronavirus Disease 2019: Epidemiology, Management, and Prevention, Current Epidemiology Reports, 10.1007/s40471-020-00261-2, 8:1, (1-8), Online publication date: 1-Mar-2021. Tsigkas G, Koufou E, Katsanos K, Patrinos P, Moulias A, Miliordos I, Almpanis G, Christodoulou I, Papanikolaou F, Dimitroula T, Kivetos A, Vardas P and Davlouros P (2021) Potential Relationship Between Lifestyle Changes and Incidence of Hospital Admissions for Acute Coronary Syndrome During the COVID-19 Lockdown, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2021.604374, 8 Chieffo A, Tarantini G, Naber C, Barbato E, Roffi M, Stefanini G, Buchanan G, Buszman P, Moreno R, Zawiślak B, Cayla G, Danenberg H, Da Silveira J, Nef H, James S, Mauri Ferre J, Voskuil M, Witt N, Windecker S, Baumbach A and Dudek D (2021) Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI), EuroIntervention, 10.4244/EIJ-D-20-01291, 16:14, (1177-1186), Online publication date: 1-Feb-2021. Logroscino G and Beghi E (2020) Stroke epidemiology and COVID-19 pandemic, Current Opinion in Neurology, 10.1097/WCO.0000000000000879, 34:1, (3-10), Online publication date: 1-Feb-2021. Goldberg S, Cash R, Peters G, Weiner S, Greenough P and Seethala R (2021) The impact of COVID‐19 on statewide EMS use for cardiac emergencies and stroke in Massachusetts, Journal of the American College of Emergency Physicians Open, 10.1002/emp2.12351, 2:1, Online publication date: 1-Feb-2021. Chew N, Sia C, Wee H, Benedict L, Rastogi S, Kojodjojo P, Ch
Referência(s)